Ibotta's 2026 State of Spend Report documented that 62% of shoppers now prioritize price over brand loyalty when making purchase decisions, according to Business Wire. The shift forces consumer packaged goods brands to rethink how they drive trial and retain buyers in a market where brand equity no longer anchors the conversion path.

The mechanics are structural. When price becomes the primary decision variable, the traditional funnel — awareness, consideration, trial, loyalty — collapses into a single gate: immediate perceived value. Shoppers who once would test a new brand because of messaging or shelf presence now require a tangible discount or rebate to move. Ibotta's data reflects behavior observed across grocery, drugstore, and mass retail channels, where cashback and coupon platforms have shifted from promotion vehicles to primary discovery tools.

The underlying mechanism is substitution velocity. In categories with functional parity — laundry detergent, snack bars, canned goods — switching costs approach zero. A shopper who previously bought Brand A out of habit will now compare unit pricing in real time, scan for available rebates, and flip to Brand B if the delta exceeds a threshold. That threshold varies by category but typically sits between 8% and 15% off shelf price. The brand's job is no longer to build preference; it is to intercept the buyer at the moment of substitution and close the gap with a discount that converts without destroying margin.

For physical-product brands operating outside traditional CPG — think supplements, pet treats, home goods — the pattern translates directly. If your product competes on function rather than identity, assume the buyer is price-sensitive first. Trial no longer comes from organic discovery or influencer endorsement alone. It comes from structured incentive: a first-order discount, a cashback offer, a bundle that lowers perceived unit cost. The play is to treat trial as a distinct line item with a known cost per acquisition, then recover margin on repeat.

The steal runs in three steps. First, establish a trial price that sits 10-15% below the nearest substitute and market it through cashback platforms, browser extensions, or your own referral mechanics. This is the hook. Second, embed the discount in a channel where the buyer is already comparison shopping: Google Shopping, Amazon with an on-page coupon, TikTok Shop with a creator code. The discount must be visible before the shopper leaves your listing. Third, use the first order to capture a repeat mechanism — email, SMS, subscription discount — that keeps subsequent orders at full margin. You are buying trial, not lifetime value, and the unit economics must reflect that.

A solo founder with a single SKU can run this for under $500 per month. Allocate $200 to first-order discounts, $150 to cashback network fees or affiliate commissions, $150 to retargeting the trial cohort via email or SMS. Track cost per trial separately from CAC. If your trial converts to second purchase at 20% or better, the initial subsidy pays out over four months. If it does not, the product or the messaging is wrong, and no amount of brand spend will fix it.

The broader pattern is deflationary pressure on differentiation. As price sensitivity rises, brands that cannot defend margin through proprietary ingredient, patent, or regulated claim will compress. The ones that survive will treat trial as a liquidity problem — how much cash can you deploy to capture a cohort before margin recovers — and structure their P&L accordingly.